BSHI 2022

22/07/2022

BSHI 2022 | British Society for Histocompatibility and Immunogenetics Conference | 13-14 Sept, 2022, London, UK The opportunity to meet us again is open, as Omixon team will be present at the 32nd Annual British Society for Histocompatibility and Immunogenetics Conference in London, UK. Our experts are looking...

ATC 2022

30/05/2022

ATC 2022 | American Transplant Congress | 4-8 June, 2022, Boston MA The opportunity to meet us again is open, as Omixon team will be present at the Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation in Boston, MA, USA. Our...

New Business Partnership For Guiding Microchimerism to Transplant Diagnostics with DigitalTRACE™

07/04/2022

Omixon is pleased to announce that we have been entered a new strategic partnership of JETA Molecular BV., based in Utrecht, The Netherlands, effective as of April 2022. This partnership will combine Omixon’s expertise as an international provider of disruptive transplant diagnostics solutions with JETA Molecular latest technological solutions...

Fecal Transplantation: Science’s Dirty Secret for Treating Cognitive and Behavioural Disorders

28/08/2019

Written by Nina Lauterbach (Field Application Scientist, Omixon) A fecal transplant is an experimental treatment in which fecal bacteria from a healthy individual are introduced in a recipient with the aim to establish a healthy diverse microbiome within the gut (1)(see Figure 1). This can be achieved by infusing...